v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | IRCT20201024049134N3 |
Full text link
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
First author
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
Contact
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
rezaghadimi@yahoo.com |
Registration date
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
2021-06-21 |
Recruitment status
Last imported at : Dec. 22, 2021, 5:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Completed |
Study design
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
RCT |
Allocation
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Randomized |
Design
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Parallel |
Masking
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Blind label |
Center
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
single-center |
Study aim
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Treatment |
Inclusion criteria
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Men and women of at least 18 years of age capable of providing informed consent. Confirmation of COVID-19 with RT-PCR in the last 24 hours Patients with outpatient treatment status (do not have any of the following): PaO2/FiO2 < 300, SpO2 < 93%, Respiratory rate > 30, Progressive lung involvements in CT scan The patient must meet at least one of the following high-risk criteria: 70 years of age or older, obesity (BMI ≥ 30 kg/m2), diabetes, uncontrolled blood pressure (systolic blood pressure > 150 mm Hg), known case of respiratory disease (Including asthma or COPD), known case of heart failure, known case of coronary artery disease, fever > 38.4°C in the last 48 hours, shortness of breath at the time of enrollment, Bicytopenia, Pancytopenia or a combination of neutrophilia and lymphopenia |
Exclusion criteria
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
The patient is currently hospitalized or needs immediate care and hospitalization. Showing any symptoms of shock or hemodynamic instability. History of inflammatory bowel disease (Crohn's disease or ulcerative colitis), chronic diarrhea or malabsorption. History of progressive neuromuscular disease. Estimated glomerular filtration rate (eGFR) < 30 ml/min in 1.73 m2 using MDRD equation. History of cirrhosis, chronic active hepatitis or severe liver disease. Pregnant, breastfeeding, or women Intending to get pregnant during the study period or 6 months after the last dose of study agent. History of colchicine use for other conditions, including Familial Mediterranean Fever or gout. History of allergic reaction or severe sensitivity to colchicine. Cancer patients undergoing active chemotherapy. |
Number of arms
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
2 |
Funding
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Babol University of Medical Sciences |
Inclusion age min
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
18 |
Inclusion age max
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
100 |
Countries
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Iran |
Type of patients
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Mild/moderate disease at enrollment |
Severity scale
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
2: Mild/moderate disease at enrollment |
Total sample size
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
500 |
primary outcome
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Require hospitalization Severely ill Death |
Notes
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
Phase
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Phase 2/Phase 3 |
Arms
Last imported at : June 22, 2021, 1:30 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
[{"arm_notes": "", "treatment_id": 310, "treatment_name": "Colchicine", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |